Received Mar 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Patient did not recived 2nd dose/possible missed dose; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose of Shingrix in Apr 2018), Zostavax (received Zostavax in February of 2013) and Zostavax (Zostavax received on 20 JUN 2018). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: Patient did not recived 2nd dose/possible missed dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 12-MAR-2025 The patient self-reported this case. Consumer stated that she was vaccinated with Zostavax in February of 2013. She received her first dose of Shingrix in April 2018. She was vaccinated 20 JUN 2018 with what she believed to be her second dose of Shingrix. Consumer stated she recently received documentation that the dose of medication she received on 20 JUN 2018 was Zostavax. Consumer was in the process of determining if the wrong vaccine was administered or if the information was documented in correctly (possible missed dose.) Consumer stated she was 71 years old now and she would have been 64 years old at the time of receiving what she thought was the second dose of Shingrix. Consumer declined to provide any demographics or additional information. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. No further information was obtained/provided.